{"version":"1.0","provider_name":"Times South Africa","provider_url":"https:\/\/timessouthafrica.com","author_name":"TSA","author_url":"https:\/\/timessouthafrica.com\/author\/tsa\/","title":"Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines - Times South Africa","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Zij5NMiqGT\"><a href=\"https:\/\/timessouthafrica.com\/sabin-vaccine-institute-receives-35-million-from-barda-with-potential-of-up-to-214-million-for-ebola-sudan-and-marburg-vaccines\/\">Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/timessouthafrica.com\/sabin-vaccine-institute-receives-35-million-from-barda-with-potential-of-up-to-214-million-for-ebola-sudan-and-marburg-vaccines\/embed\/#?secret=Zij5NMiqGT\" width=\"600\" height=\"338\" title=\"&#8220;Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines&#8221; &#8212; Times South Africa\" data-secret=\"Zij5NMiqGT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Sabin Vaccine Institute Awarded BARDA Contract With Funding Potential up to $214M for Ebola Sudan and Marburg Vaccines WASHINGTON, Jan. 12, 2023 (GLOBE NEWSWIRE) \u2014 The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to $214 million to [\u2026]","thumbnail_url":"https:\/\/ci4.googleusercontent.com\/proxy\/dEJv9V6u31GxLvsoMg759hyjmKwHmOegf1ILW1oAeUxCQUntAKpatO6QFrymQVuzQ-i1KUbnzlOPRWci5fb6q90OSVSomMg0YK4jVU7WfmmSiL7JpBOgUq6YfwH-R2_tUjWPw-6e5sPmh_u3bBmTMx_W8pesfPxA_V5Z-xdWt1j3qEX5dfSpc_j_WdeawSk9J8-KIj1lx6H45J28dUlOT706=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/539c9127-e5d6-4b32-9e89-780f7461314b\/medium\/sabin-vaccine-institute-awarded-barda-contract-with-funding.jpg"}